These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18698001)

  • 41. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.
    Patrick KS; Williard RL; VanWert AL; Dowd JJ; Oatis JE; Middaugh LD
    J Med Chem; 2005 Apr; 48(8):2876-81. PubMed ID: 15828826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.
    Calipari ES; Ferris MJ; Salahpour A; Caron MG; Jones SR
    Nat Commun; 2013; 4():2720. PubMed ID: 24193139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
    dos Santos Pereira M; Sathler MF; Valli Tda R; Marques RS; Ventura AL; Peccinalli NR; Fraga MC; Manhães AC; Kubrusly R
    PLoS One; 2015; 10(10):e0141249. PubMed ID: 26509840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cocaine produces conditioned place aversion in mice with a cocaine-insensitive dopamine transporter.
    O'Neill B; Tilley MR; Gu HH
    Genes Brain Behav; 2013 Feb; 12(1):34-8. PubMed ID: 23083326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
    Froimowitz M; Gu Y; Dakin LA; Nagafuji PM; Kelley CJ; Parrish D; Deschamps JR; Janowsky A
    J Med Chem; 2007 Jan; 50(2):219-32. PubMed ID: 17228864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.
    Jiang SZ; Sweat S; Dahlke SP; Loane K; Drossel G; Xu W; Tejeda HA; Gerfen CR; Eiden LE
    J Neurosci; 2021 Jan; 41(4):711-725. PubMed ID: 33268547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Place preference and microdialysis studies with two derivatives of methylphenidate.
    Gatley SJ; Meehan SM; Chen R; Pan DF; Schechter MD; Dewey SL
    Life Sci; 1996; 58(24):PL345-52. PubMed ID: 8649202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters.
    Gatley SJ; Pan D; Chen R; Chaturvedi G; Ding YS
    Life Sci; 1996; 58(12):231-9. PubMed ID: 8786705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
    Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
    Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2'-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding.
    Seale TW; Avor K; Singh S; Hall N; Chan HM; Basmadjian GP
    Neuroreport; 1997 Nov; 8(16):3571-5. PubMed ID: 9427328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys.
    Seu E; Lang A; Rivera RJ; Jentsch JD
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):505-19. PubMed ID: 18604598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monoamine transporter as a target molecule for psychostimulants].
    Sora I; Igari M; Yamamoto H; Ikeda K
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):450-4. PubMed ID: 18079593
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
    Volkow ND; Swanson JM
    Am J Psychiatry; 2003 Nov; 160(11):1909-18. PubMed ID: 14594733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.